Instem awarded $1m deal
Stafford-based Instem Life Science Systems has won a four-year contract worth more than $1m (£634,700).
The company, which provides IT applications for the healthcare market, agreed the deal with an unnamed client said to be one of the world's "five largest" pharmaceutical organisations.
The client will use Instem's Provantis solution suite, described as a "pre-clinical data management system".
Phil Reason, chief executive of Instem, said: "We are delighted to have contracted additional Provantis modules to such a prestigious top five pharmaceutical company, and it is testament to our quality offering that we have replaced their incumbent system. It is a continuing trend in the industry that large pharma are consolidating their IT systems and vendors as the cost of research and development rises.
"These trends are encouraging for Instem as we are well poised to support organisations of all sizes as they look to meet the demand for growth while increasing efficiencies."
A contract has been signed for an initial four years and is worth a total consideration of $1.08m with online deployment starting this year.
